Key players operating in the Smart Insulin Pen Market Size are Bayer AG, Henkel AG & Co. KgaA, Avon Products Inc., Johnson & Johnson Inc., Kao Corporation, Beiersdorf AG, Groupe Clarins SA, Revlon Inc., Shiseido Co. Ltd., Unilever PLC, Procter & Gamble, L'Oréal SA, Lotus Herbals Pvt. Ltd., and The Estée Lauder Companies Inc., among others. Bayer AG maintains its dominance in the smart insulin pen market with its popular product, Bayer Contour Next One, being one of the top selling smart insulin pens worldwide.

The growing prevalence of diabetes across the globe along with the rising awareness regarding smart insulin systems is driving adoption of smart insulin pens. Smart insulin pens allow patients to remotely track important metrics like insulin intake timing and dosage by automating data transfers to mobile health apps for ease of management. This enhances patients' involvement in self-therapy as well as cooperation with healthcare providers.

Get more insights on Smart Insulin Pen Market